Coherus BioSciences Correlations

CHRS Stock  USD 1.65  0.06  3.51%   
The current 90-days correlation between Coherus BioSciences and Avalo Therapeutics is 0.13 (i.e., Average diversification). The correlation of Coherus BioSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Coherus BioSciences Correlation With Market

Average diversification

The correlation between Coherus BioSciences and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Coherus BioSciences and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coherus BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
For more information on how to buy Coherus Stock please use our How to Invest in Coherus BioSciences guide.

Moving together with Coherus Stock

  0.63RDACU Rising Dragon AcquisitionPairCorr
  0.69TRV The Travelers CompaniesPairCorr
  0.77JPM JPMorgan ChasePairCorr
  0.81CAT CaterpillarPairCorr
  0.68IBM International Business Earnings Call This WeekPairCorr
  0.85GE GE Aerospace Earnings Call This WeekPairCorr
  0.8JNJ Johnson JohnsonPairCorr

Moving against Coherus Stock

  0.72KO Coca Cola Earnings Call This WeekPairCorr
  0.31T ATT Inc Earnings Call This WeekPairCorr
  0.31VZ Verizon CommunicationsPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GNLXCRBP
GNLXPYXS
IVVDPYXS
CRBPPYXS
CDXSOABI
PYXSAVTX
  

High negative correlations

IVVDVOR
VORPYXS
VORAVTX
GNLXVOR
OABIAVTX
CRBPVOR

Risk-Adjusted Indicators

There is a big difference between Coherus Stock performing well and Coherus BioSciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Coherus BioSciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
AVTX  4.19  1.52  0.38 (0.84) 2.82 
 16.09 
 27.37 
PYXS  5.03  1.82  0.45  1.17  3.15 
 14.12 
 40.09 
VOR  4.64 (0.35) 0.00 (0.28) 0.00 
 11.95 
 41.55 
OABI  2.67 (0.23) 0.00 (0.62) 0.00 
 5.59 
 17.86 
IVVD  7.41  1.93  0.24 (3.67) 6.18 
 15.24 
 99.46 
CRBP  3.03  1.36  0.38 (4.59) 2.25 
 9.61 
 22.13 
CGEN  2.90  0.51  0.12 (0.22) 2.56 
 8.84 
 26.88 
GNLX  3.38  0.82  0.20  1.70  3.27 
 8.22 
 29.95 
OBIO  3.17  0.20  0.03 (1.12) 5.06 
 9.76 
 25.17 
CDXS  2.67 (0.10) 0.00 (0.06) 0.00 
 6.64 
 17.24 

Coherus BioSciences Corporate Management

Vladimir VexlerChief Scientific OfficerProfile
Bryan McmichaelPrincipal AccountingProfile
Michael ChenSenior TradeProfile
Theresa LavalleeChief BoardProfile
MRCP MDChief OfficerProfile
Rebecca SunshineChief OfficerProfile